Kevin is a senior group leader at the CRUK Cambridge Institute where his lab works in the field of molecular imaging. The primary focus of their work is early detection of tumour treatment response with the aim of developing imaging methods that could be used in early phase clinical trials to get an indication of drug efficacy, and subsequently in the clinic to guide treatment in individual patients. In the case of pancreatic cancer, they have shown that a metabolic imaging technique that they have developed can be used to monitor disease progression.